Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,668,455
+$1,318,257 QoQ
Shares Held
129,438
+575.3% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 96.87495171433427.ToString("F0")%
Shared 0.ToString("F0")%
None 3.125048285665724.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. EYPT ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in EYPT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,668,455 | 129,438 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $350,198 | 19,168 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $254,497 | 17,872 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,199,729 | 446,305 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,401,016 | 442,992 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $314,941 | 42,274 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $14,358 | 1,797 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $16,269 | 1,870 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $669,894 | 32,409 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $750,728 | 32,485 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,152 | 2,397 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,598 | 1,678 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,898 | 986 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $8,967 | 2,562 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $545 | 69 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $306 | 39 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,215,674 | 182,360 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,896,000 | 400,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $41 | 4 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||